Pharma companies need aggressive R&D and patent filing: Experts
News | 10 June 2012
MUMBAI: Indian pharmaceutical companies need to go for aggressive research and patent filing like China and Japan and unless spending on R&D is scaled up, it would be difficult to create new molecules, industry experts said. "Our Indian companies are ...
Click on the link to read the full article at Economic Times
(This link will open in a new window)
- US FDA advisory panel backs approval of Merck & Co's suvorexant, but only at lower doses
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- Italy's pharma market slump set to continue, warns GlobalData
